The effect of variation of the size
of headgroup as well as the
length of hydrocarbon tail of nonionic surfactants on the photophysics
and rotational-relaxation dynamics of a promising biological photosensitizer,
norharmane, (NHM) has been investigated. The series of nonionic micelles
employed for the study belongs to Triton X family (allowing the variation
in poly(ethylene oxide) (PEO) chain length) and Tween family (providing
access to vary the alkyl chain length of the surfactant tails). The
spectral deciphering of the photophysics of the drug (NHM) within
the series of the nonionic micelles reveals remarkable influence of
binding of the drug with the micelles on the prototropic equilibrium
which is notably favored toward the neutral species of the drug over
the cationic counterpart. The strength of drug–micelle binding
interaction as well as the extent of transformation of the cation
⇌ neutral prototropic equilibrium is found to be enormously
governed by the variation of the headgroup size and the alkyl chain
length of the surfactants. To this end, the equilibrium constant (Keq) and free energy change (ΔG) for cation ⇌ neutral prototropic transformation of the drug
as a function of the micellar parameters have been meticulously explored
from emission studies and comprehensively rationalized under the provision
of the micellar hydration model, that is, the differential extents
of water penetration to micellar units as a function of varying thickness
of the palisade layer and hence a variation in the polarity of the
micellar microenvironments. The significant enhancement in steady-state
fluorescence anisotropy of NHM in micellar environments compared to
that in bulk aqueous buffer phase substantiates the location of the
drug in motionally constrained regions introduced by the nonionic
micelles. Further, all these lines of arguments are effectively corroborated
from time-resolved fluorescence experiments with particular emphasis
on time-resolved anisotropy decay study of the drug within the micellar
aggregates